nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—FGFR3—skin epidermis—vulva cancer	0.0374	0.0374	CbGeAlD
Pazopanib—FGF1—skin epidermis—vulva cancer	0.0259	0.0259	CbGeAlD
Pazopanib—FGFR2—skin epidermis—vulva cancer	0.0245	0.0245	CbGeAlD
Pazopanib—MAP3K9—epithelium—vulva cancer	0.0206	0.0206	CbGeAlD
Pazopanib—MAP3K9—mammalian vulva—vulva cancer	0.0179	0.0179	CbGeAlD
Pazopanib—KIT—skin epidermis—vulva cancer	0.017	0.017	CbGeAlD
Pazopanib—TAOK1—uterine cervix—vulva cancer	0.0153	0.0153	CbGeAlD
Pazopanib—ITK—mammalian vulva—vulva cancer	0.0147	0.0147	CbGeAlD
Pazopanib—SH2B3—uterine cervix—vulva cancer	0.0144	0.0144	CbGeAlD
Pazopanib—TAOK1—urethra—vulva cancer	0.0141	0.0141	CbGeAlD
Pazopanib—MAP3K9—vagina—vulva cancer	0.0138	0.0138	CbGeAlD
Pazopanib—TAOK1—mammalian vulva—vulva cancer	0.0134	0.0134	CbGeAlD
Pazopanib—SH2B3—urethra—vulva cancer	0.0133	0.0133	CbGeAlD
Pazopanib—SH2B3—mammalian vulva—vulva cancer	0.0126	0.0126	CbGeAlD
Pazopanib—FGFR3—epithelium—vulva cancer	0.0122	0.0122	CbGeAlD
Pazopanib—FGFR3—uterine cervix—vulva cancer	0.0121	0.0121	CbGeAlD
Pazopanib—RIOK2—uterine cervix—vulva cancer	0.0121	0.0121	CbGeAlD
Pazopanib—BMPR1B—epithelium—vulva cancer	0.0121	0.0121	CbGeAlD
Pazopanib—ITK—vagina—vulva cancer	0.0114	0.0114	CbGeAlD
Pazopanib—RIOK2—urethra—vulva cancer	0.0111	0.0111	CbGeAlD
Pazopanib—FGFR3—urethra—vulva cancer	0.0111	0.0111	CbGeAlD
Pazopanib—STK36—uterine cervix—vulva cancer	0.0108	0.0108	CbGeAlD
Pazopanib—PI4KB—uterine cervix—vulva cancer	0.0107	0.0107	CbGeAlD
Pazopanib—RIOK2—mammalian vulva—vulva cancer	0.0106	0.0106	CbGeAlD
Pazopanib—FGFR3—mammalian vulva—vulva cancer	0.0106	0.0106	CbGeAlD
Pazopanib—LIMK2—uterine cervix—vulva cancer	0.0105	0.0105	CbGeAlD
Pazopanib—TAOK1—vagina—vulva cancer	0.0104	0.0104	CbGeAlD
Pazopanib—STK36—urethra—vulva cancer	0.00997	0.00997	CbGeAlD
Pazopanib—PI4KB—urethra—vulva cancer	0.00982	0.00982	CbGeAlD
Pazopanib—SH2B3—vagina—vulva cancer	0.00978	0.00978	CbGeAlD
Pazopanib—FLT4—epithelium—vulva cancer	0.0095	0.0095	CbGeAlD
Pazopanib—STK36—mammalian vulva—vulva cancer	0.00949	0.00949	CbGeAlD
Pazopanib—PIP4K2C—uterine cervix—vulva cancer	0.00937	0.00937	CbGeAlD
Pazopanib—PI4KB—mammalian vulva—vulva cancer	0.00934	0.00934	CbGeAlD
Pazopanib—FGFR1—uterine cervix—vulva cancer	0.0093	0.0093	CbGeAlD
Pazopanib—LIMK2—mammalian vulva—vulva cancer	0.00917	0.00917	CbGeAlD
Pazopanib—MAP3K9—lymph node—vulva cancer	0.00895	0.00895	CbGeAlD
Pazopanib—MAP3K2—uterine cervix—vulva cancer	0.00888	0.00888	CbGeAlD
Pazopanib—PIP4K2C—urethra—vulva cancer	0.00861	0.00861	CbGeAlD
Pazopanib—FGFR1—urethra—vulva cancer	0.00854	0.00854	CbGeAlD
Pazopanib—FGF1—epithelium—vulva cancer	0.00844	0.00844	CbGeAlD
Pazopanib—LCK—uterine cervix—vulva cancer	0.00832	0.00832	CbGeAlD
Pazopanib—STK16—vagina—vulva cancer	0.00831	0.00831	CbGeAlD
Pazopanib—PIP4K2C—mammalian vulva—vulva cancer	0.0082	0.0082	CbGeAlD
Pazopanib—RIOK2—vagina—vulva cancer	0.00818	0.00818	CbGeAlD
Pazopanib—FGFR1—mammalian vulva—vulva cancer	0.00813	0.00813	CbGeAlD
Pazopanib—FGFR2—epithelium—vulva cancer	0.00797	0.00797	CbGeAlD
Pazopanib—FGFR2—uterine cervix—vulva cancer	0.0079	0.0079	CbGeAlD
Pazopanib—LCK—urethra—vulva cancer	0.00764	0.00764	CbGeAlD
Pazopanib—FLT1—epithelium—vulva cancer	0.00739	0.00739	CbGeAlD
Pazopanib—ITK—lymph node—vulva cancer	0.00738	0.00738	CbGeAlD
Pazopanib—STK36—vagina—vulva cancer	0.00735	0.00735	CbGeAlD
Pazopanib—FLT1—uterine cervix—vulva cancer	0.00733	0.00733	CbGeAlD
Pazopanib—LCK—mammalian vulva—vulva cancer	0.00728	0.00728	CbGeAlD
Pazopanib—EPHB6—uterine cervix—vulva cancer	0.00724	0.00724	CbGeAlD
Pazopanib—PI4KB—vagina—vulva cancer	0.00724	0.00724	CbGeAlD
Pazopanib—LIMK2—vagina—vulva cancer	0.00711	0.00711	CbGeAlD
Pazopanib—STK10—uterine cervix—vulva cancer	0.00694	0.00694	CbGeAlD
Pazopanib—TAOK3—uterine cervix—vulva cancer	0.00691	0.00691	CbGeAlD
Pazopanib—FLT1—urethra—vulva cancer	0.00673	0.00673	CbGeAlD
Pazopanib—TAOK1—lymph node—vulva cancer	0.00672	0.00672	CbGeAlD
Pazopanib—EPHB6—urethra—vulva cancer	0.00666	0.00666	CbGeAlD
Pazopanib—FLT1—mammalian vulva—vulva cancer	0.00641	0.00641	CbGeAlD
Pazopanib—PIP4K2C—vagina—vulva cancer	0.00635	0.00635	CbGeAlD
Pazopanib—TAOK3—urethra—vulva cancer	0.00635	0.00635	CbGeAlD
Pazopanib—EPHB6—mammalian vulva—vulva cancer	0.00634	0.00634	CbGeAlD
Pazopanib—SH2B3—lymph node—vulva cancer	0.00632	0.00632	CbGeAlD
Pazopanib—FGFR1—vagina—vulva cancer	0.0063	0.0063	CbGeAlD
Pazopanib—KDR—epithelium—vulva cancer	0.00625	0.00625	CbGeAlD
Pazopanib—AURKC—lymph node—vulva cancer	0.00622	0.00622	CbGeAlD
Pazopanib—KDR—uterine cervix—vulva cancer	0.00619	0.00619	CbGeAlD
Pazopanib—MAP2K5—uterine cervix—vulva cancer	0.00619	0.00619	CbGeAlD
Pazopanib—STK10—mammalian vulva—vulva cancer	0.00607	0.00607	CbGeAlD
Pazopanib—TAOK3—mammalian vulva—vulva cancer	0.00604	0.00604	CbGeAlD
Pazopanib—CSF1R—uterine cervix—vulva cancer	0.00604	0.00604	CbGeAlD
Pazopanib—PLK4—lymph node—vulva cancer	0.00569	0.00569	CbGeAlD
Pazopanib—KDR—urethra—vulva cancer	0.00569	0.00569	CbGeAlD
Pazopanib—MAP2K5—urethra—vulva cancer	0.00569	0.00569	CbGeAlD
Pazopanib—LCK—vagina—vulva cancer	0.00564	0.00564	CbGeAlD
Pazopanib—CSF1R—urethra—vulva cancer	0.00555	0.00555	CbGeAlD
Pazopanib—KIT—epithelium—vulva cancer	0.00554	0.00554	CbGeAlD
Pazopanib—KIT—uterine cervix—vulva cancer	0.00549	0.00549	CbGeAlD
Pazopanib—KDR—mammalian vulva—vulva cancer	0.00542	0.00542	CbGeAlD
Pazopanib—MAP2K5—mammalian vulva—vulva cancer	0.00542	0.00542	CbGeAlD
Pazopanib—PDGFRB—epithelium—vulva cancer	0.00541	0.00541	CbGeAlD
Pazopanib—STK16—lymph node—vulva cancer	0.00538	0.00538	CbGeAlD
Pazopanib—PDGFRB—uterine cervix—vulva cancer	0.00536	0.00536	CbGeAlD
Pazopanib—RIOK2—lymph node—vulva cancer	0.00529	0.00529	CbGeAlD
Pazopanib—CSF1R—mammalian vulva—vulva cancer	0.00529	0.00529	CbGeAlD
Pazopanib—BMPR1B—lymph node—vulva cancer	0.00524	0.00524	CbGeAlD
Pazopanib—KIT—urethra—vulva cancer	0.00504	0.00504	CbGeAlD
Pazopanib—FLT1—vagina—vulva cancer	0.00496	0.00496	CbGeAlD
Pazopanib—PDGFRB—urethra—vulva cancer	0.00493	0.00493	CbGeAlD
Pazopanib—EPHB6—vagina—vulva cancer	0.00491	0.00491	CbGeAlD
Pazopanib—KIT—mammalian vulva—vulva cancer	0.0048	0.0048	CbGeAlD
Pazopanib—STK36—lymph node—vulva cancer	0.00475	0.00475	CbGeAlD
Pazopanib—STK10—vagina—vulva cancer	0.0047	0.0047	CbGeAlD
Pazopanib—PDGFRB—mammalian vulva—vulva cancer	0.00469	0.00469	CbGeAlD
Pazopanib—TAOK3—vagina—vulva cancer	0.00468	0.00468	CbGeAlD
Pazopanib—PI4KB—lymph node—vulva cancer	0.00468	0.00468	CbGeAlD
Pazopanib—PDGFRA—vagina—vulva cancer	0.00465	0.00465	CbGeAlD
Pazopanib—LIMK2—lymph node—vulva cancer	0.0046	0.0046	CbGeAlD
Pazopanib—KDR—vagina—vulva cancer	0.0042	0.0042	CbGeAlD
Pazopanib—MAP2K5—vagina—vulva cancer	0.0042	0.0042	CbGeAlD
Pazopanib—FLT4—lymph node—vulva cancer	0.00413	0.00413	CbGeAlD
Pazopanib—PIP4K2C—lymph node—vulva cancer	0.00411	0.00411	CbGeAlD
Pazopanib—CSF1R—vagina—vulva cancer	0.0041	0.0041	CbGeAlD
Pazopanib—FGFR1—lymph node—vulva cancer	0.00407	0.00407	CbGeAlD
Pazopanib—MAP3K2—lymph node—vulva cancer	0.00389	0.00389	CbGeAlD
Pazopanib—KIT—vagina—vulva cancer	0.00372	0.00372	CbGeAlD
Pazopanib—FGF1—lymph node—vulva cancer	0.00367	0.00367	CbGeAlD
Pazopanib—LCK—lymph node—vulva cancer	0.00365	0.00365	CbGeAlD
Pazopanib—PDGFRB—vagina—vulva cancer	0.00363	0.00363	CbGeAlD
Pazopanib—FLT1—lymph node—vulva cancer	0.00321	0.00321	CbGeAlD
Pazopanib—EPHB6—lymph node—vulva cancer	0.00317	0.00317	CbGeAlD
Pazopanib—STK10—lymph node—vulva cancer	0.00304	0.00304	CbGeAlD
Pazopanib—TAOK3—lymph node—vulva cancer	0.00303	0.00303	CbGeAlD
Pazopanib—ABCG2—uterine cervix—vulva cancer	0.00301	0.00301	CbGeAlD
Pazopanib—PDGFRA—lymph node—vulva cancer	0.00301	0.00301	CbGeAlD
Pazopanib—ABCG2—urethra—vulva cancer	0.00277	0.00277	CbGeAlD
Pazopanib—KDR—lymph node—vulva cancer	0.00271	0.00271	CbGeAlD
Pazopanib—MAP2K5—lymph node—vulva cancer	0.00271	0.00271	CbGeAlD
Pazopanib—CSF1R—lymph node—vulva cancer	0.00265	0.00265	CbGeAlD
Pazopanib—ABCG2—mammalian vulva—vulva cancer	0.00264	0.00264	CbGeAlD
Pazopanib—KIT—lymph node—vulva cancer	0.00241	0.00241	CbGeAlD
Pazopanib—PDGFRB—lymph node—vulva cancer	0.00235	0.00235	CbGeAlD
Pazopanib—CYP2C8—vagina—vulva cancer	0.0021	0.0021	CbGeAlD
Pazopanib—ABCG2—vagina—vulva cancer	0.00204	0.00204	CbGeAlD
Pazopanib—ABCB1—epithelium—vulva cancer	0.0015	0.0015	CbGeAlD
Pazopanib—ABCB1—uterine cervix—vulva cancer	0.00149	0.00149	CbGeAlD
Pazopanib—ABCB1—urethra—vulva cancer	0.00137	0.00137	CbGeAlD
Pazopanib—ABCG2—lymph node—vulva cancer	0.00132	0.00132	CbGeAlD
Pazopanib—ABCB1—mammalian vulva—vulva cancer	0.0013	0.0013	CbGeAlD
Pazopanib—ABCB1—vagina—vulva cancer	0.00101	0.00101	CbGeAlD
Pazopanib—ABCB1—lymph node—vulva cancer	0.000651	0.000651	CbGeAlD
